NEWS: CPRX Catalyst receives $1.07M from exercise of warrants • 8:59 AM Catalyst Pharmaceutical (CPRX) has received $1.07M from the exercise of stock warrants to buy 1.03M shares. The company issued the warrants in its IPO in May last year. Catalyst doesn't appear to have provided any further details in the 8-K disclosing the news. The amount received indicates a price of $1.04 a share vs yesterday's close of $1.31.